FirstIgnite is supporting the commercialization of Florida International University’s new device for assisting visually impaired patients. By utilizing the remaining functional areas of the retina in individuals with age-related macular degeneration (AMD) and glaucoma, this technology allows patients to visualize complete images of the world, similar to what a normal eye would perceive. This technology is flexible, as it can be reprogrammed to adapt to the progression of AMD and glaucoma, even as these conditions affect larger portions of a patient’s visual field. With a period of training, patients can even distinguish between the central and peripheral parts of projected images.

This technology aims to improve the vision of individuals with impaired central and peripheral vision, such as AMD and glaucoma patients. Additionally, it is applicable to the military and defense sectors. Valued at $10.52 billion in 2022, the global age-related macular degeneration market is projected to grow to $17.99 billion by 2030

Florida International University’s new device for assisting visually impaired patients is ready for collaboration (licensing, partnerships, industry feedback, etc.). Is your company the right fit? If you’d be available for a conversation with the Florida International University team, you can schedule a time directly on their team’s calendar here.